検索
Close this search box.
検索
Subscriber Log In

ソート・リーダーシップ

製薬業界における大きな問題についての私たちの洞察にご注目ください。

ソート・リーダーシップ・ライブラリーは、データに基づいて作成された最新のレポート、インフォグラフィック、記事をお届けします。

最新コンテンツ

A Digital Health Innovation Report by Galen Growth, powered by HealthTech Alpha
As part of Evaluate’s partnership with Galen Growth, we bring you their latest report on Digital Health Innovation in US Health Systems, built using data from HealthTech Alpha. In the vast and complex US healthcare system, it’s challenging for all types...
続きを読む
Banner-Galen-Growth-Report
EVALUATING: Neurology
Neurology is experiencing a resurgence, highlighted by increased deal activity, clinical advancements and a notable IPO. This revival, though less conspicuous than obesity’s, emerges from years of underinvestment, resulting in a landscape filled...
続きを読む
Biopharma-2022-Whats-Next-featured-image
Antibody Drug Conjugates Report
Antibody-drug conjugates (ADCs) are the hottest real estate in oncology, attracting billions from big pharma: Pfizer acquired Seagen for $43 billion AbbVie invested over $10 billion in ImmunoGen Merck committed $4 billion upfront, with a potential total...
続きを読む
Antibody-Drug-Conjugates-Report-featured-image
その他のコンテンツ

注目の寄稿者